Omega Healthcare Investors (OHI) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Omega Healthcare Investors

NYSE•Real Estate•REIT - Healthcare Facilities

$47.13-0.21(<0.01%)After hours

Market Cap

$14.08B

P/E

15.7x

P/S

11.0x

P/B

2.6x

Omega Healthcare Investors, Inc. is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK and Canada. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States. The firm is incorporated in Maryland.

How this company scores

ExcellentMetricSide Score: 83/100

Strongest: Profitability (25/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability25/25

Growth22/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality21/25

Strengths

Growing revenueStrong marginsHigh ROERising earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 15.7x5y range 14.8x – 34.0x

Currently below its 20-quarter median.

P/S · 11.0x5y range 6.7x – 11.2x

Currently above its 20-quarter median.

P/B · 2.6x5y range 1.8x – 2.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Share Dilution

Red Flag

Shares outstanding increased 13.8% — significant dilution, likely from stock compensation or capital raises.

Price & Volume

Market Cap $14.08B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.28B
Q. Revenue: $328.25M
TTM EBITDA: $1.11B
TTM Op. Income: $776.56M
Q. Op. Income: $330.91M
TTM Net Income: $895.17M
Q. Net Income: $379.67M
EPS: $1.21
Shares Out.: $298.85M

$1.28B in TTM revenue grew 15.0% YoY, reaching $328.25M last quarter. TTM EBITDA of $1.11B and TTM operating income of $776.56M show growth is flowing through to the bottom line. TTM net income of $895.17M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 125.7%
Op. Margin: 100.8%
Net Margin: 115.7%

Op. margin of 100.8% is up 61.7% YoY — cost efficiency is improving. Net margin at 115.7% Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 15.7x
P/S Ratio: 11.0x
P/B Ratio: 2.6x

At 15.7x P/E, the stock trades within typical market levels. P/S of 11.0x and P/B of 2.6x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 3 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $10.01B
Cash: $39.04M
Long-Term Debt: N/A
Book Value: $5.39B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $217.72M
TTM Free Cash Flow: $815.96M
FCF Margin: 63.6%
FCF / Net Income: 0.9

TTM FCF of $815.96M on $217.72M in operating cash flow. The FCF / Net Income ratio of 0.9x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 5% — a weakening trend.